You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-68kDa Neurofilament antibody (ab24520)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-68kDa Neurofilament antibody
See all 68kDa Neurofilament products (15) ...

Description

Chicken polyclonal to 68kDa Neurofilament

Tested applications

IF, WBmore details

Cross reactivity

Reacts with

Mouse, Rat, Chicken, Cat, Human

Immunogen

Tissue / cell preparation (Cow): bovine intermediate filaments prepared from spinal cords.

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: 10mM Sodium Azide
Constituents: PBS

Concentration

Concentration information loading...

Purification notes

The IgY preparation was made by chloroform delipidation of egg yolk followed by polyethylene glycol precipitation.

Primary antibody notes

To raise this antibody bovine intermediate filaments were prepared from spinal cords by the method of Delacourte et al. and the cytoskeletal material was dissolved in 6M urea. To ensure greater specificity for NFL, animals were boosted with recombinant mouse NFL purified from bacteria. This antibody was generated in chicken by standard procedures and immunoglobulin was extracted from egg yolk. This is the chicken homologue of mammalian IgG and can be used in the same general way, with the caveat that this type of antibody does not bind either Protein A or Protein G.

Clonality

Polyclonal

Isotype

IgY

Applications

Show applications key

Our Abpromise guarantee covers the use of ab24520 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • IF

     
  • WB

     

Application notes

IF: 1/5000. WB (using chemiluminescence): 1/10000 or lower. Predicted molecular weight: 63 kDa.
Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Neurofilaments usually contain three intermediate filament proteins: L, M, and H which are involved in the maintenance of neuronal caliber.

Involvement in disease

Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 1F (CMT1F) [MIM:607734]. CMT1F is a form of Charcot-Marie-Tooth disease, the most common inherited disorder of the peripheral nervous system. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathy or CMT1, and primary peripheral axonal neuropathy or CMT2. Neuropathies of the CMT1 group are characterized by severely reduced nerve conduction velocities (less than 38 m/sec), segmental demyelination and remyelination with onion bulb formations on nerve biopsy, slowly progressive distal muscle atrophy and weakness, absent deep tendon reflexes, and hollow feet. CMT1F is characterized by onset in infancy or childhood (range 1 to 13 years).
Defects in NEFL are the cause of Charcot-Marie-Tooth disease type 2E (CMT2E) [MIM:607684]. CMT2E is an autosomal dominant form of Charcot-Marie-Tooth disease type 2. Neuropathies of the CMT2 group are characterized by signs of axonal regeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy.

Sequence similarities

Belongs to the intermediate filament family.

Domain

The extra mass and high charge density that distinguish the neurofilament proteins from all other intermediate filament proteins are due to the tailpiece extensions. This region may form a charged scaffolding structure suitable for interaction with other neuronal components or ions.

Post-translational
modifications

O-glycosylated.
Phosphorylated in the Head and Rod regions by the PKC kinase PKN1, leading to inhibit polymerization.

Target information above from: UniProt accessionP07196 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 68 kDa neurofilament protein antibody
  • 68kDa neurofilament protein antibody
  • CMT 1F antibody
  • CMT 2E antibody
  • CMT1F antibody
  • CMT2E antibody
  • FLJ53642 antibody
  • Light molecular weight neurofilament protein antibody
  • NEFL antibody
  • Neurofilament light antibody
  • Neurofilament light polypeptide 68kD antibody
  • Neurofilament light polypeptide 68kDa antibody
  • Neurofilament light polypeptide antibody
  • Neurofilament protein, light chain antibody
  • Neurofilament subunit NF L antibody
  • Neurofilament triplet L protein antibody
  • NF 68 antibody
  • NF L antibody
  • NF-L antibody
  • NF68 antibody
  • NFL antibody
  • NFL_HUMAN antibody
see all

References for Anti-68kDa Neurofilament antibody (ab24520)

ab24520 has not yet been referenced specifically in any publications.

Publishing research using ab24520? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"